SCHEMBL2381380

SCHEMBL2381380

CCCC(NS(=O)(=O)c1ccc(Cl)cc1)C(=O)OC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.54
ALDH1A1 P00352 3/20 0.54
NPSR1 Q6W5P4 2/20 0.54
RECQL P46063 1/20 0.54
MMP2 P08253 6/20 0.48
ADAMTS5 Q9UNA0 1/20 0.48
CYP3A4 P08684 2/20 0.48
TSHR P16473 2/20 0.48
CYP2C19 P33261 2/20 0.48
THRB P10828 1/20 0.48
NFKB1 P19838 1/20 0.48
HTR2A P28223 1/20 0.48
ADRA1A P35348 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
CYP1A2 P05177 1/20 0.47
CYP2C9 P11712 1/20 0.47
MAPK1 P28482 1/20 0.47
S1PR1 P21453 1/20 0.46
MMP9 P14780 3/20 0.46
MMP1 P03956 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27455490 0.89 LMNA (0.54) LMNAALDH1A1NPSR1RECQLMMP2
SCHEMBL3065763 0.89 MMP2 (0.50) LMNAALDH1A1NPSR1RECQLMMP2
SCHEMBL10076123 0.89 MMP2 (0.50) LMNAALDH1A1NPSR1RECQLMMP2
SCHEMBL5875639 0.86 MMP2 (0.60) MMP2ADAMTS5MMP9MMP1MMP13
SCHEMBL8839754 0.86 MMP2 (0.60) MMP2ADAMTS5MMP9MMP1MMP13
SCHEMBL2383878 0.82 MMP2 (0.47) LMNAALDH1A1NPSR1MMP2ADAMTS5
SCHEMBL8839327 0.82 ALDH1A1 (0.50) LMNAALDH1A1NPSR1MMP2ADAMTS5
SCHEMBL8839275 0.82 ALDH1A1 (0.50) LMNAALDH1A1NPSR1MMP2ADAMTS5
SCHEMBL8839537 0.82 ALDH1A1 (0.50) LMNAALDH1A1NPSR1MMP2ADAMTS5
SCHEMBL27430355 0.82 MMP2 (0.53) MMP2ADAMTS5MMP9MMP1MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8022225-B2 Triazole derivative TAISHO PHARMACEUTICAL CO., LTD (JP) 2011-09-20 US disclosed
US-20090131438-A1 Triazole derivative TAISHO PHARMACEUTICAL CO., LTD (JP) 2009-05-21 US disclosed
EP-1798226-A1 TRIAZOLE DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD (JP) 2007-06-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131438-A1 Triazole derivative S1PR3, S1PR1, S1PR2 LMNA 4808/4885ALDH1A1 2924/4885NPSR1 68/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.